SOLV Solventum Corporation

NYSE
$88.65

Solventum Corporation (SOLV) is expected to report earnings on February 4, 2027, after the market close. The consensus earnings estimate is $1.77 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +2.5% since its last earnings release on November 5, 2026.

Solventum Missed Expectations, Raises Guidance In-line with Estimates
Thursday, November 5, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 4
Thursday · 4:05 PM ET
Earnings Whisper
-
vs $1.77
Rev est $2.09B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $89.97

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Solventum Corporation

Solventum is an independent healthcare company. Its business segment includes Medical Surgical, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum is based in ST. PAUL, Minn.

Sector

Healthcare

Industry

Medical Instruments/Supply

Charts powered in part by Lightweight Charts™ by TradingView.